Caffeine might ease anxiety and depression by calming brain inflammation

Key Points:

• A systematic review of 17 rodent studies found that caffeine consistently reduces anxiety- and depression-like behaviors by lowering brain inflammation, as published in Translational Psychiatry.
• Caffeine blocks A2A adenosine receptors on brain immune cells, preventing neuroinflammation that disrupts neurotransmitter balance and contributes to mood disorders.
• In anxiety models, caffeine promoted exploratory behavior and decreased pro-inflammatory cytokines like interleukin-6, while in depression models, it maintained motivation and reward-seeking behaviors comparable to standard antidepressants.
• Related compounds such as caffeic acid and green tea extract showed similar anti-inflammatory and mood-improving effects, though some benefits appeared specifically linked to caffeine.
• Limitations include the use of only adult male rodents, variable caffeine doses (some toxic), and the challenge of translating animal findings to human mental health, highlighting the need for further research on safe and effective caffeine use.